aripiprazole 1mgml oral solution
dr reddy's laboratories (uk - aripiprazole - oral solution - 1mg/1ml
kaletra 80mg20mg1ml oral solution
abbvie ltd - ritonavir; lopinavir - oral solution - 20mg/1ml ; 80mg/1ml
abilify 1mgml oral solution
otsuka pharmaceuticals (u.k. - aripiprazole - oral solution - 1mg/1ml
martapan 2mg/5ml oral solution
martindale pharmaceuticals ltd - dexamethasone sodium phosphate - oral solution - 400microgram/1ml
aripiprazole 1mgml oral solution
wockhardt uk ltd - aripiprazole - oral solution - 1mg/1ml
aripiprazole 1mgml oral solution
mylan - aripiprazole - oral solution - 1mg/1ml
aripiprazole 1mg/ml oral solution
wockhardt uk limited - aripiprazole - oral solution - 1 milligram(s)/millilitre - other antipsychotics; aripiprazole - other antipsychotics - aripiprazole is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older. aripiprazole is indicated for the treatment of moderate to severe manic episodes in bipolar i disorder and for the prevention of a new manic episode in adults who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment
apo-olanzapine odt olanzapine 10 mg orally disintegrating tablet blister pack
arrotex pharmaceuticals pty ltd - olanzapine, quantity: 10 mg - tablet, orally disintegrating - excipient ingredients: magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; mannitol; sucralose; carmellose calcium - - treatment of schizophrenia and related psychoses;. - short-term treatment, alone or in combination with lithium or valproate, of acute manic episodes associated with bipolar i disorder;. - preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.
apo-olanzapine odt olanzapine 5 mg orally disintegrating tablet blister pack
arrotex pharmaceuticals pty ltd - olanzapine, quantity: 5 mg - tablet, orally disintegrating - excipient ingredients: microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; carmellose calcium; sucralose; mannitol - - treatment of schizophrenia and related psychoses;. - short-term treatment, alone or in combination with lithium or valproate, of acute manic episodes associated with bipolar i disorder;. - preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.
apo-olanzapine odt olanzapine 15 mg orally disintegrating tablet blister pack
arrotex pharmaceuticals pty ltd - olanzapine, quantity: 15 mg - tablet, orally disintegrating - excipient ingredients: carmellose calcium; sucralose; mannitol; colloidal anhydrous silica; microcrystalline cellulose; magnesium stearate - - treatment of schizophrenia and related psychoses;. - short-term treatment, alone or in combination with lithium or valproate, of acute manic episodes associated with bipolar i disorder;. - preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.